| 000 | 00925 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250516130529.0 | ||
| 264 | 0 | _c20130730 | |
| 008 | 201307s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1517/14728222.2013.740461 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGondi, Christopher S | |
| 245 | 0 | 0 |
_aCathepsin B as a cancer target. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _cMar 2013 |
||
| 300 |
_a281-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aRao, Jasti S | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 17 _gno. 3 _gp. 281-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728222.2013.740461 _zAvailable from publisher's website |
| 999 |
_c22397272 _d22397272 |
||